human live bone generation
Created on 08 Apr 2016
Our project deals with a method for human live bone generation in vitro for use as autologous bone graft for clinical use in the frame of personalized medicine
Our project deals with a method for human live bone generation in vitro for use as autologous bone graft for clinical use in the frame of personalized medicine
Avilex Pharma has developed an exceptionally high-affinity inhibitor of the intracellular scaffolding protein, postsynaptic density protein 95 (PSD-95), which bridges the NMDA glutamate receptor and neuronal nitric oxide synthase (nNOS). Avilex Ph ...
Target is to use interfamilial asymmetric protoplast fusion under advanced sucrose and nitrate starvation between albino haploid wheat cell and haploid soybean microplast for obtaining nitrogen fixing wheat. Cell fusion is a rapid i ...
The Milieu Intérieur project, "Genetic & Environmental Determinants Of Immune Phenotype variance: Establishing A Path Towards Personalized Medicine", is an ambitious population-based study coordinated by the Institut Past ...
The Up2Europe idea came from a group of freelancers who work around European projects. It has finally been realised by one of them with the support of the others.
Up2Europe is the first ideas accelerator for European projects , and aims to create a virtual community for Up and coming professionals in European projects.
We believe that this kind of virtual network has not yet reached its full potential and aim to explore it fully.
We want to give the European community a specific platform where users can submit their ideas and see them accelerated into real life projects.
We want to give all available tools for users to build connections in regional areas between future partners and their local European consultants.
European institutions don't know about Up yet, but our goal is to be part of them and we hope to work together in the future as a technological partner as we share the same vision.
To contact Up2Europe use the Contact Form
Plaese Log In to See This Section